1. Home
  2. BUJA vs NVNO Comparison

BUJA vs NVNO Comparison

Compare BUJA & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BUJA
  • NVNO
  • Stock Information
  • Founded
  • BUJA 2022
  • NVNO 1987
  • Country
  • BUJA Malaysia
  • NVNO United States
  • Employees
  • BUJA N/A
  • NVNO N/A
  • Industry
  • BUJA Blank Checks
  • NVNO Medical/Dental Instruments
  • Sector
  • BUJA Finance
  • NVNO Health Care
  • Exchange
  • BUJA Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • BUJA 54.3M
  • NVNO 59.4M
  • IPO Year
  • BUJA 2023
  • NVNO N/A
  • Fundamental
  • Price
  • BUJA $10.99
  • NVNO $3.28
  • Analyst Decision
  • BUJA
  • NVNO
  • Analyst Count
  • BUJA 0
  • NVNO 0
  • Target Price
  • BUJA N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • BUJA 4.1K
  • NVNO 96.4K
  • Earning Date
  • BUJA 01-01-0001
  • NVNO 10-31-2024
  • Dividend Yield
  • BUJA N/A
  • NVNO N/A
  • EPS Growth
  • BUJA N/A
  • NVNO N/A
  • EPS
  • BUJA N/A
  • NVNO N/A
  • Revenue
  • BUJA N/A
  • NVNO N/A
  • Revenue This Year
  • BUJA N/A
  • NVNO N/A
  • Revenue Next Year
  • BUJA N/A
  • NVNO N/A
  • P/E Ratio
  • BUJA $30.09
  • NVNO N/A
  • Revenue Growth
  • BUJA N/A
  • NVNO N/A
  • 52 Week Low
  • BUJA $10.32
  • NVNO $3.01
  • 52 Week High
  • BUJA $12.18
  • NVNO $6.97
  • Technical
  • Relative Strength Index (RSI)
  • BUJA 66.75
  • NVNO 39.99
  • Support Level
  • BUJA $10.95
  • NVNO $3.25
  • Resistance Level
  • BUJA $10.98
  • NVNO $3.68
  • Average True Range (ATR)
  • BUJA 0.00
  • NVNO 0.15
  • MACD
  • BUJA -0.00
  • NVNO 0.03
  • Stochastic Oscillator
  • BUJA 100.00
  • NVNO 9.20

About BUJA Bukit Jalil Global Acquisition 1 Ltd.

Bukit Jalil Global Acquisition 1 Ltd is a blank check company.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Share on Social Networks: